ArticleJournal for immunotherapy of cancer2022

Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation.

Guoliang Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.